-
Uncategorized2 months ago
Lilly, Novo dip as proposed Medicare coverage for GLP-1 pilot thrown off balance
Two of the biggest insurance providers have expressed reluctance to participate in the government’s BALANCE program that would have made GLP-1 drugs more affordable to patients.
-
Uncategorized2 months ago
Amid US ordeal, Moderna wins EU approval for flu/COVID-19 combo shot
In the U.S., Moderna withdrew its approval application for the combination vaccine in May last year and the timeline for resubmission remains uncertain.
-
Uncategorized2 months agoModerna continues bird flu vax study, but limits work in the U.S.
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning. Big news: I’ve convinced at least...
-
Uncategorized2 months ago
Merck steps up as ‘meaningful competitor’ to Gilead with HIV pill approval
The newly approved HIV drug Idvynso will also help Merck diversify as loss of exclusivity looms over its top-selling product, the mega-blockbuster cancer drug Keytruda.
-
Uncategorized2 months ago
Antigen‑Stabilized Nanobody Probes Enable On‑Demand, Multicolor Protein Imaging
Fluorescent probes have reshaped how biologists study living systems, making it possible to watch viruses invade cells, follow the cell’s internal waste‑disposal machinery, and track the...
-
Uncategorized2 months agoAre MAHA snacks really better for you? Nutrition experts parse a grocery aisle gold rush
Vani Hari has 2.3 million followers on Instagram, and about as many ideas for healthy food swaps. An entrepreneur and influential food activist in the Make...
-
Uncategorized2 months ago
The 5 largest IPOs in biopharma history
With an IPO raise of $625 million, Kailera Therapeutics now holds the new record for the largest public market debut.
-
Uncategorized2 months ago
The next phase of diabetes care
As technology becomes more integrated and personalized, experts say the biggest opportunity in diabetes management is reducing everyday burdens.
-
Uncategorized2 months ago
Denali CEO’s ‘greatest professional moment’ arrives as rare disease drug launches
Denali CEO’s ‘greatest professional moment’ arrives as rare disease drug launches
-
Uncategorized2 months ago
Why key opinion leader enthusiasm often doesn’t predict future commercial success
While prominent physicians can provide companies with valuable guidance during development, their perspective is limited when it comes to projecting how well or how readily a...
